Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Molecular Assemblies, Inc.

Latest From Molecular Assemblies, Inc.

Finance Watch: Arbor, Acrivon, Bit.Bio Close VC Mega-Rounds

Private Company Edition: Arbor is developing drugs based on proprietary gene editors, Acrivon is applying proteomics to precision cancer therapies, and is producing differentiated cell products. Also, Marengo launches with $80m, Sanofi invests up to $60m in Gyroscope and Shasqi raises $50m.

Financing Innovation

Start-Up Previews, July 2015

This month's profiles: InPress Technologies, MaRVis Medical, Medherant, Molecular Assemblies, MyoPowers, Potrero Medical, Revolution Medicines, and Rivanna Medical

BioPharmaceutical Medical Device

Molecular Assemblies Inc.

Molecular Assemblies Inc. aims to commercialize a “green” approach to DNA synthesis called EcoDNA. The start-up expects the biologically and enzymatically based technology to produce DNA strands up to 30 times longer than those made with the classical chemical methods.

See All

Company Information

  • Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Large Molecule
    • Nanotechnology, Chips, etc.
    • Synthesis Technologies, Production Processes
    • Drug Discovery Tools
      • Genomics-Proteomics